Results: 50

Bone marrow cell migration to the heart in a chimeric mouse model of acute chagasic disease

Mem. Inst. Oswaldo Cruz; 112 (8), 2017
BACKGROUND Chagas disease is a public health problem caused by infection with the protozoan Trypanosoma cruzi. There is currently no effective therapy for Chagas disease. Although there is some evidence for the beneficial effect of bone marrow-derived cells in chagasic disease, the mechanisms underlying...

Trypanosoma cruzi I genotype among isolates from patients with chronic Chagas disease followed at the Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ, Brazil)

ABSTRACT INTRODUCTION: Trypanosoma cruzi is the etiologic agent of Chagas disease in humans, mainly in Latin America. Trypanosome stocks were isolated by hemoculture from patients followed at Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ) and studied using different approaches. METH...

Aspectos imunológicos da infecção por Trypanosoma Cruzi - persistência do parasita e autoimunidade

Apesar de a doença de Chagas ter sido intensamente estudada ao longo de mais de um século desde sua descoberta, existem lacunas de conhecimento com relação aos mecanismos fisiopatogênicos que levam ao desenvolvimento tardio da cardiomiopatia chagásica crônica. Um aspecto intrigante da doença é a...

Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens

Abstract: INTRODUCTION: Chagas disease currently affects 5.7 million people in Latin America and is emerging in non-endemic countries. There is no consensus concerning the efficacy of trypanocidal therapy for patients with the chronic form of the disease. We evaluated cardiac function and sociodemograph...

Antichagásicos potenciais: síntese e modelagem molecular de híbridos de hidrazonas e liberadores de óxido nítrico

A doença de Chagas é uma parasitose extremamente negligenciada, cujo agente etiológico é o protozoário Trypanosoma cruzi. Atualmente, 21 países da América Latina são considerados regiões endêmicas, onde 75-90 milhões de pessoas estão expostas à infecção, 6-7 milhões estão infectadas e ma...

Lineamientos básicos del tratamiento etiológico de enfermedad de Chagas
Guiding the etiological treatment of Chagas disease

Medicina (B.Aires); 75 (4), 2015

Alteraciones electrocardiográficas en pacientes con enfermedad de chagas. Hospital José Rangel de Villa de Cura. 1998 - 2008
Electrocardiographic abnormalities in patients with. chagas disease. Hospital José Rangel of Villa de Cura. 1998 - 2008

Rev. Inst. Nac. Hig; 43 (2), 2012
Objetivo: Analizar las principales alteraciones electrocardiográficas en pacientes con Enfermedad de Chagas que asistieron al Hospital José Rangel de Villa de Cura Edo. Aragua, entre los años 1998 -2008. Se realizó una revisión de historias clínicas y electrocardiogramas de la Unidad de Archivos de...

Guías clínicas de la enfermedad de Chagas 2006: parte V: diagnóstico de laboratorio
Guidelines for the Chagas disease: part V: laboratory diagnosis of Chagas disease

Rev. chil. infectol; 25 (5), 2008
In this fifth part of Guidelines for Chagas disease, diagnostic techniques for Trypanosoma cruzi infection in humans are reviewed, the interpretation of laboratory results and an algorithm for laboratory diagnosis in immunocompetent hosts are presented. Chagas disease may be diagnosed by three kinds of t...

Prevalencia de la enfermedad de Chagas en niños en edad escolar de las zonas marginales de Asunciòn

La enfermedad de chagas es un problema de salud pública en América Latina debida a su amplia distribución, elevada prevalencia y por la magnitud del daño que produce y las dificultades para lograr su control. En Paraguay la enfermedad se encuentra distribuìda principalmente en los departamento de Pa...